Mayra Gyovana Leite Belém

Mayra Gyovana Leite Belém

Auto-generated profile, based on publicly available information

Mayra Gyovana Leite Belém

Laboratory of Microorganism Biology, Oswaldo Cruz Foundation, Porto Velho, Rondônia, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
RRR. S. Rodrigues
R. S. Rodrigues
ACA. G. Carvalho
A. G. Carvalho
MSM. E. P. Silva
M. E. P. Silva
IRI. V. G. Ramos
I. V. G. Ramos
NLN. C. S. Lima
N. C. S. Lima
NMN. B. Matos
N. B. Matos
Klebsiella spp. is an opportunistic pathogen which poses a significant threat to public health, especially due to antimicrobial resistance and biofilm formation. This study aimed to determine the antibiotic resistance profile, biofilm formation and β-lactamases production in Klebsiella spp. strains from clinical samples obtained from hospitalized patients, health professionals and hospital environment of intensive care units (ICUs) in Brazilian Amazon. The strains were obtained from clinical samples in different hospitals and identified using molecular techniques. The antimicrobial susceptibility was investigated via disk diffusion and microdilution. Biofilm formation was evaluated using a microtiter plate assay, while the extended-spectrum β-lactamases (ESBL) and carbapenemases production was assessed via disk approximation tests and combined disk tests, respectively. A total of 226 Klebsiella spp. strains were identified, with 141 coming from patients hospitalized in ICUs, 54 from healthcare workers, and 31 from hospital structures. Collection sites that showed the highest frequencies of isolated bacteria were the armpit (43,3%), oral cavity (42.6%), nasal cavity (70.4%), beds (54.8%) and mechanical ventilation (19.4%). Klebsiella spp. isolates from hospitalized patients and hospital ICU environments showed a high frequency of resistance (>50%) to the antibiotics, cefuroxime, cefotaxime, ceftriaxone, ciprofloxacin and aztreonam, and greater sensitivity (>70%) to carbapenems, amikacin and polymyxin B. Samples obtained from hospital structures (74.2%) and patients (51.8%) exhibited a high rate of multidrug resistant (MDR) isolates. In addition, 29% of Klebsiella isolates were found to produce ESBL and 15.5% carbapenemases. Biofilm formation was observed in 58.4% (132/226) of the isolates, with percentages of 64.5% (91/141) in hospitalized patients, 51.6% (16/31) on hospital structures, and 46.3% (25/54) among healthcare professionals. These results indicated a high percentage of antibiotics resistance and MDR in isolates from hospital structures and patients, which also showed ability to produce biofilms, ESBL and carbapenemases. Our findings reinforce the need to monitor resistance and adopt measures aimed at preventing the spread of MDR bacteria in ICUs.

11 April 2025 in Brazilian Journal of Oral Sciences
Verified
Journal Article
Open access
PDF file
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
LSLuccas Manoel de Melo Suica
Luccas Manoel de Melo Suica
RRRenata Santos Rodrigues
Renata Santos Rodrigues
IRIzabelly Vitória Gotara Ramos
Izabelly Vitória Gotara Ramos
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
NMNajla Benevides Matos
Najla Benevides Matos
Patients admitted in the Intensive Care Units (ICUs) often experience various oral health issues during their hospitalization, which can lead to a shift in their oral flora from Gram-positive to pathogenic Gram-negative bacteria, including Pseudomonas aeruginosa. Aim: This study aimed to identify the colonization of P. aeruginosa in the oral cavity of ICU patients, as well as to assess its antimicrobial susceptibility profile, phenotypic resistance mechanisms, and biofilm-forming capacity. Methods: Oral cavity samples were collected from patients in ICUs across three public hospitals in Porto Velho, Rondônia, Brazil. Antimicrobial susceptibility testing was performed using the disk diffusion method, phenotypic research on resistance determinants was conducted using a disk method with and without the addition of enzymatic inhibitors, and biofilm formation was assessed by measuring absorbance in microplates. Results: A total of 114 oral cavity samples were obtained, with 28% showing colonization by P. aeruginosa. The antimicrobial susceptibility profile revealed that 93.7% of the isolates were susceptible to Polymyxin B. The highest rate of non-susceptibility was observed with levofloxacin (46.8%), followed by carbapenems: imipenem (43.7%) and meropenem (40.6%). Additionally, 37.5% of the isolates were classified as multidrug-resistant (MDR). In phenotypic research for carbapenemases, 35.7% of the isolates were positive for plasmid-mediated AmpC, and 14.3% were positive for Metallo-β-lactamases. Regarding biofilm production, 75% of the isolates were classified as moderate/strong biofilm producers. Conclusion: Therefore, oral cavity colonization by P. aeruginosa in ICU patients is evident, with notable multidrug resistance to antibiotics, highlighting the need for vigilant monitoring and effective oral hygiene practices for these patients.

1 January 2024 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
RRRenata Santos Rodrigues
Renata Santos Rodrigues
MRMariana Delfino Rodrigues
Mariana Delfino Rodrigues
LOLetícia Pereira de Oliveira
Letícia Pereira de Oliveira
MBMayra Gyovana Leite Belém
Mayra Gyovana Leite Belém
NMNajla Benevides Matos
Najla Benevides Matos
Objectives: to assess the prevalence and epidemiological factors associated with group B Streptococcus (GBS) colonization in pregnant women in Porto Velho City, Rondônia. Methods: GBS was identified and isolated by genotypic and microbiological methods from rectovaginal samples of pregnant women between 35 and 37 weeks of gestation. Epidemiological data were collected using questionnaires and their correlation with colonization was assessed. The antimicrobial susceptibility profile was determined by disk diffusion method. Results: a total of 22.5% (102/453) pregnant women were colonized with GBS. A higher level of colonization was observed at the vaginal tract (17.6%), compared to the rectal area. We did not find any sociodemographic or obstetric factors associated with an increased risk of GBS colonization. All strains were susceptible to antibiotics penicillin, ampicillin, cefazolin, and ceftriaxone. In contrast, the rates of resistance to tetracycline (74.1%), erythromycin (14.1%), and clindamycin (3.5%) were observed. Conclusion: the prevalence of GBS as well as the absence of predictors of colonization demonstrated the need for universal screening for GBS in all pregnant women in the region. In addition, we showed that the first-line antibiotics recommended for prophylaxis are still good options for the prevention of neonatal GBS disease in the region.

1 January 2024 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
RRRenata Santos Rodrigues
Renata Santos Rodrigues
MRMariana Delfino Rodrigues
Mariana Delfino Rodrigues
LOLetícia Pereira de Oliveira
Letícia Pereira de Oliveira
MBMayra Gyovana Leite Belém
Mayra Gyovana Leite Belém
NMNajla Benevides Matos
Najla Benevides Matos
Resumo Objetivos: avaliar a prevalência e os fatores epidemiológicos associados à colonização por Streptococcus do grupo B (GBS) em gestantes na cidade de Porto Velho, Rondônia. Métodos: GBS foi identificado e isolado por métodos genotípicos e microbiológicos a partir de amostras retovaginais de grávidas com 35-37 semanas de gestação. Os dados epidemiológicos foram coletados através de questionários e sua correlação com a presença de colonização foi avaliada. O perfil de susceptibilidade antimicrobiana foi determinado pelo método de disco-difusão. Resultado: um total de 22.5% (102/453) gestantes foram colonizadas por GBS. Um nível mais alto de colonização foi observado no sítio vaginal (17.6%) em comparação ao sítio retal. Não encontramos nenhum fator sociodemográfico ou obstétrico associado a um risco aumentado de colonização por GBS. Todas as amostras foram suscetíveis aos antibióticos penicilina, ampicilina, cefazolina e ceftriaxona. Em contraste, as taxas de resistência à tetraciclina (74.1%), eritromicina (14.1%) e clindamicina (3.5%) foram observadas. Conclusões: a prevalência de GBS, bem como a ausência de preditores de colonização, demonstraram a necessidade de triagem universal para GBS em todas as gestantes da região. Além disso, mostramos que os antimicrobianos de primeira linha recomendados para profilaxia são boas opções para a prevenção da doença GBS neonatal na região.

25 April 2026 in International Microbiology
Verified
Journal Article
Open access
ACAnjo Gabriel Carvalho
Anjo Gabriel Carvalho
MBMayra Gyovana Leite Belém
Mayra Gyovana Leite Belém
ESErilene de Lima Sinos
Erilene de Lima Sinos
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
RRRenata Santos Rodrigues
Renata Santos Rodrigues
NMNajla Benevides Matos
Najla Benevides Matos
Group B Streptococcus (GBS) is a leading cause of preterm birth and neonatal infection. The COVID-19 pandemic substantially altered healthcare access, antibiotic use, and pathogen circulation. However, its influence on GBS remains poorly understood. This study evaluated temporal changes in GBS colonization, serotypes, and antimicrobial susceptibility among pregnant women in the Brazilian Amazon before, during, and after the COVID-19 pandemic. A total of 1,449 pregnant women at 35–37 weeks of gestation attending public health units in Porto Velho, Brazil, between February 2018 and November 2023 were included. Rectovaginal samples were cultured for GBS detection. Capsular serotyping and antimicrobial susceptibility testing were performed using standardized methods. Colonization prevalence, serotype distribution, and resistance profiles were compared across pre-pandemic, pandemic, and post-pandemic periods. Overall GBS colonization was detected in 20.7% (300/1,449) of participants, with variation across periods (22.6% before the pandemic, 21% during, and 19% after). Serotype Ia predominated (39%), followed by serotypes V (15.8%), II (14.1%), Ib (11.9%), III (10.2%), IV (5.1%), and VI (4%). Serotype distribution varied across periods without statistically significant differences. Non-susceptibility profiles differed significantly among serotypes. All isolates were susceptible to penicillin, ampicillin, cefazolin, and vancomycin. Increased non-susceptibility was observed for macrolides and levofloxacin, with multidrug-resistant (MDR) isolates rising from 5.7% to 15.9% post-pandemic. Together, these findings demonstrate temporal variation in GBS colonization, serotype distribution, and antimicrobial resistance across pre-, during-, and post-pandemic periods. While colonization, serotype distribution, and β-lactam susceptibility remained stable, significant increases in non-susceptibility to macrolides and levofloxacin, along with higher proportions of MDR profiles, were observed in later periods. These results highlight the importance of continued surveillance and provide relevant epidemiological insights to inform vaccine implementation and public health strategies in the post-pandemic era. The online version contains supplementary material available at 10.1007/s10123-026-00832-1.

21 March 2026 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMarcos Eduardo Passos da Silva
Marcos Eduardo Passos da Silva
LSLuccas Manoel de Melo Suica
Luccas Manoel de Melo Suica
RRRenata Santos Rodrigues
Renata Santos Rodrigues
MCMárlon Grégori Flôres Custódio
Márlon Grégori Flôres Custódio
VFValcimar Batista Ferreira
Valcimar Batista Ferreira
NMNajla Benevides Matos
Najla Benevides Matos
Introduction: Pseudomonas aeruginosa is one of the leading agents of Healthcare-Associated Infections (HAIs), especially in Intensive Care Units (ICUs), where its intrinsic resistance, biofilm-forming ability, and acquisition of β-lactamase genes contribute to therapeutic failure and increased morbidity. Understanding the resistance mechanisms and clonal dynamics of this pathogen in clinical and hospital environments is essential for effective infection control. Results: Overall, 30.5% of the isolates were classified as MDR, with higher non-susceptibility rates to imipenem (41.2%) and meropenem (35.6%). Moderate/strong biofilm formation was observed in 77.3% of the isolates. A high prevalence of β-lactamase genes was detected, particularly blaCTX-M (38.8%), blaTEM (29.1%), blaGES (13.9%), and blaSHV (4.1%), whereas carbapenemase genes were infrequent ( blaVIM , blaKPC , blaIMP ; 1.8%). The blaCTX-M gene was significantly associated with MDR profiles and resistance to cefepime and ceftazidime. PFGE identified 16 clonal groups among 28 isolates, indicating transmission among patients, hospital surfaces, and different hospitals. MLST revealed 16 sequence types, including four novel STs, with predominance of ST3079. Methods: A total of 216 P. aeruginosa isolates obtained from hospitalized patients and hospital surfaces in three public hospitals in Porto Velho, Western Amazon, Brazil, were analyzed. Antimicrobial susceptibility was determined according to CLSI guidelines. Biofilm formation was evaluated in 96-well microplates. β-lactamase and carbapenemase genes were detected by PCR. Genetic relatedness was investigated by PFGE and MLST in multidrug-resistant (MDR) or carbapenem-resistant isolates. Conclusion: P. aeruginosa from ICU patients and hospital surfaces showed high multidrug resistance, strong biofilm production, and widespread β-lactamase genes, particularly blaCTX-M , a key determinant of the MDR phenotype. Clonal dissemination across hospitals and sources highlights the need for strengthened infection control, continuous molecular surveillance, and antimicrobial stewardship.